The transition of sputum inflammatory cell profiles is variable in stable asthma patients
10.5415/apallergy.2017.7.1.19
- Author:
Bomi SHIN
1
;
Hyouk Soo KWON
;
So Young PARK
;
Tae Bum KIM
;
Hee Bom MOON
;
You Sook CHO
Author Information
1. Division of Allergy and Clinical Immunology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. yscho@amc.seoul.kr
- Publication Type:Original Article
- Keywords:
Asthma;
Sputum inflammatory cell;
Eosinophils;
Phenotype
- MeSH:
Asthma;
Eosinophilia;
Eosinophils;
Follow-Up Studies;
Humans;
Inflammation;
Phenotype;
Respiratory Function Tests;
Sputum
- From:
Asia Pacific Allergy
2017;7(1):19-28
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: The sputum inflammatory cell profile is an important indicator for classifying asthma phenotypes. OBJECTIVE: To investigate if sputum inflammatory cell profile remains stable and there are different characteristics between groups that show different profile over time in stable asthmatic patients. METHODS: A total of 149 asthmatic patients, who were clinically stable at the time of sputum examination and had undergone sputum analysis twice, were subjected to a detailed review. Eosinophilic inflammation was diagnosed when the proportion of the sputum eosinophils was >3%. We divided the patients into 4 groups according to the transition patterns of their sputum profiles: group 1, persistent eosinophilia; group 2, eosinophilic to noneosinophilic; group 3, noneosinophilic to eosinophilic; and group 4, persistent noneosinophilia. The results of the pulmonary function tests and other clinical parameters were compared between these 4 groups. RESULTS: Thirty-four of the initially eosinophilic asthmatic patients (39.5%; 34 of 86 patients) demonstrated noneosinophilic airway inflammation at their second sputum examination, and 24 of the initially noneosinophilic patients (38.1%; 24 of 63 patients) demonstrated eosinophilic airway inflammation at follow-up. Various clinical parameters, except the blood eosinophil count, demonstrated no significant differences between the eosinophilic and noneosinophilic asthmatic patients or among the 4 groups. CONCLUSION: A substantial proportion of asthmatic patients who demonstrate a certain sputum inflammatory cell profile at the initial examination demonstrated profile transition in clinically stable settings over time. The clinical significance of using induced sputum analysis to phenotype stable asthmatic patients requires further evaluation.
